Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Hummel TR, Chow LM, Fouladi M, Franz D.

Paediatr Drugs. 2013 Feb;15(1):29-42. doi: 10.1007/s40272-012-0002-4. Review.

PMID:
23329387
2.

Small molecule inhibitors in children with malignant gliomas.

Herrington B, Kieran MW.

Pediatr Blood Cancer. 2009 Sep;53(3):312-7. doi: 10.1002/pbc.21950. Review.

PMID:
19434732
4.

Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.

Sturm D, Pfister SM, Jones DTW.

J Clin Oncol. 2017 Jul 20;35(21):2370-2377. doi: 10.1200/JCO.2017.73.0242. Epub 2017 Jun 22. Review.

PMID:
28640698
5.

Treatment of high-grade glioma in children and adolescents.

MacDonald TJ, Aguilera D, Kramm CM.

Neuro Oncol. 2011 Oct;13(10):1049-58. doi: 10.1093/neuonc/nor092. Epub 2011 Jul 22. Review.

6.

Invasion is not an independent prognostic factor in high-grade glioma.

Narayana A, Perretta D, Kunnakkat S, Gruber D, Golfinos J, Parker E, Medabalmi P, Zagzag D, Pat Eagan RN, Gruber M.

J Cancer Res Ther. 2011 Jul-Sep;7(3):331-5. doi: 10.4103/0973-1482.87039.

7.

Antiangiogenic therapy for high-grade gliomas.

Chamberlain MC, Raizer J.

CNS Neurol Disord Drug Targets. 2009 Jun;8(3):184-94. Review.

PMID:
19601816
8.

An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting.

Kyritsis AP, Levin VA.

Cancer Chemother Pharmacol. 2011 May;67(5):971-83. doi: 10.1007/s00280-011-1617-9. Epub 2011 Mar 27. Review.

PMID:
21442438
9.

Bevacizumab in recurrent high-grade pediatric gliomas.

Narayana A, Kunnakkat S, Chacko-Mathew J, Gardner S, Karajannis M, Raza S, Wisoff J, Weiner H, Harter D, Allen J.

Neuro Oncol. 2010 Sep;12(9):985-90. doi: 10.1093/neuonc/noq033. Epub 2010 Apr 2.

10.

Targeted therapy in pediatric low-grade glioma.

Kilday JP, Bartels UK, Bouffet E.

Curr Neurol Neurosci Rep. 2014 Apr;14(4):441. doi: 10.1007/s11910-014-0441-0. Review.

PMID:
24604059
11.

The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.

Dasgupta T, Haas-Kogan DA.

Front Oncol. 2013 May 10;3:110. doi: 10.3389/fonc.2013.00110. eCollection 2013.

12.

Adjuvant chemotherapy in the treatment of high grade gliomas.

Lonardi S, Tosoni A, Brandes AA.

Cancer Treat Rev. 2005 Apr;31(2):79-89. Review.

PMID:
15847978
13.

Thalamic high-grade gliomas in children: a distinct clinical subset?

Kramm CM, Butenhoff S, Rausche U, Warmuth-Metz M, Kortmann RD, Pietsch T, Gnekow A, Jorch N, Janssen G, Berthold F, Wolff JE.

Neuro Oncol. 2011 Jun;13(6):680-9. doi: 10.1093/neuonc/nor045.

14.

Procarbazine, lomustine and vincristine for recurrent high-grade glioma.

Parasramka S, Talari G, Rosenfeld M, Guo J, Villano JL.

Cochrane Database Syst Rev. 2017 Jul 26;7:CD011773. doi: 10.1002/14651858.CD011773.pub2. Review.

PMID:
28744879
15.

Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.

Thorarinsdottir HK, Santi M, McCarter R, Rushing EJ, Cornelison R, Jales A, MacDonald TJ.

Clin Cancer Res. 2008 Jun 1;14(11):3386-94. doi: 10.1158/1078-0432.CCR-07-1616.

16.

Cilengitide in bevacizumab-refractory high-grade glioma: two case reports and critical review of the literature.

Lombardi G, Zustovich F, Farina P, Polo V, Farina M, Della Puppa A, Bertorelle R, Gardiman MP, Berti F, Zagonel V.

Anticancer Drugs. 2012 Aug;23(7):749-53. doi: 10.1097/CAD.0b013e3283520e2c. Review.

PMID:
22382388
17.

Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas.

Chamberlain MC.

Cancer. 2010 Sep 1;116(17):3988-99. doi: 10.1002/cncr.25256. Review.

18.

Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma.

Drappatz J, Lee EQ, Hammond S, Grimm SA, Norden AD, Beroukhim R, Gerard M, Schiff D, Chi AS, Batchelor TT, Doherty LM, Ciampa AS, Lafrankie DC, Ruland S, Snodgrass SM, Raizer JJ, Wen PY.

J Neurooncol. 2012 Mar;107(1):133-8. doi: 10.1007/s11060-011-0717-z. Epub 2011 Oct 8.

PMID:
21984064
19.

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N.

Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Review.

PMID:
25242542
20.

New chemotherapy options for the treatment of malignant gliomas.

Soffietti R, Rudà R, Trevisan E.

Anticancer Drugs. 2007 Jul;18(6):621-32. Review.

PMID:
17762390

Supplemental Content

Support Center